Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2021

View Archived Issues

New mouse model allows investigation of EP3 receptor function in the kidney tubule

Researchers identify markers of adrenomyeloneuropathy severity

NN-1213 lowers appetite and body weight in animal models of obesity

IL-33, a potential new therapeutic target for diabetic kidney disease

Beta2-integrins as potential targets for ANCA-mediated glomerulonephritis

Jiangsu Simcere Pharmaceutical presents new SERDs

Novartis and collaborators describe new antiviral compounds

New HIF-2alpha inhibitors discovered at NiKang Therapeutics

Intarcia Therapeutics identifies new neuropeptide Y receptor agonists

Effective attenuation of renal fibrosis with a potent HIPK2 inhibitor

Edigene and University of Wisconsin-Madison collaborate on in vivo RNA editing therapies

CN Bio and iiCON partner to validate novel organ-on-a-chip infection models for COVID-19

New cystic fibrosis mouse models allow testing of therapies for W1282X nonsense mutations

Spiny mice can regenerate damaged kidneys without fibrosis

HDAC8 targeting for treating AKI shows promise

Cellaria announces new products for modeling tumor microenvironment

Frequency Therapeutics unveils new research program for hearing loss and MS

Massachusetts General Hospital to conduct preclinical trial of Angany's BP/AH-01 for peanut allergy

synTac platform delivers primary and costimulatory signals to activate virus-specific immune T cells

Gritstone's self-amplifying mRNA vaccination protected against SARS-CoV-2 challenge in NHPs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...